Orforglipron is an oral, non-peptide glucagon-like peptide-1 receptor agonist (GLP-1 RA) under clinical development for the treatment of type 2 diabetes and obesity.
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea